239 related articles for article (PubMed ID: 30142796)
1. Comparison of neonatal outcomes and live-birth defects after progestin-primed ovarian stimulation versus conventional ovarian stimulation for in vitro fertilization: A large retrospective cohort study.
Wang N; Lin J; Zhu Q; Fan Y; Wang Y; Fu Y; Kuang Y
Medicine (Baltimore); 2018 Aug; 97(34):e11906. PubMed ID: 30142796
[TBL] [Abstract][Full Text] [Related]
2. Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles.
Chen H; Wang Y; Lyu Q; Ai A; Fu Y; Tian H; Cai R; Hong Q; Chen Q; Shoham Z; Kuang Y
Fertil Steril; 2015 May; 103(5):1194-1201.e2. PubMed ID: 25813280
[TBL] [Abstract][Full Text] [Related]
3. Live-Birth Outcomes and Congenital Malformations After Progestin-Primed Ovarian Stimulation in Maternal Endometriosis.
Liang Z; Wang Y; Kuang Y
Drug Des Devel Ther; 2020; 14():5459-5467. PubMed ID: 33328724
[TBL] [Abstract][Full Text] [Related]
4. Neonatal outcomes and congenital malformations in children born after dydrogesterone application in progestin-primed ovarian stimulation protocol for IVF: a retrospective cohort study.
Huang J; Xie Q; Lin J; Lu X; Wang N; Gao H; Cai R; Kuang Y
Drug Des Devel Ther; 2019; 13():2553-2563. PubMed ID: 31440037
[TBL] [Abstract][Full Text] [Related]
5. Neonatal outcomes and congenital malformations in children born after progestin-primed ovarian stimulation protocol.
Li D; Hu Z; Chen Q; Chai W; Cai R; Kuang Y; Lu X
Front Endocrinol (Lausanne); 2022; 13():965863. PubMed ID: 36440198
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial to compare the live birth rate of the first frozen embryo transfer following the progestin-primed ovarian stimulation protocol vs. the antagonist protocol in women with an anticipated high ovarian response.
Chen ZQ; Ai A; Zhang Y; Li H; Wang JY; Wang L; Ng EHY
Fertil Steril; 2024 Jun; 121(6):937-945. PubMed ID: 38272383
[TBL] [Abstract][Full Text] [Related]
7. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
[TBL] [Abstract][Full Text] [Related]
8. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
Xiao ZN; Peng JL; Yang J; Xu WM
Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
[TBL] [Abstract][Full Text] [Related]
9. Progestin-primed ovarian stimulation is a feasible method for poor ovarian responders undergoing in IVF/ICSI compared to a GnRH antagonist protocol: A retrospective study.
Huang P; Tang M; Qin A
J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):99-102. PubMed ID: 30321608
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the cumulative live birth rates after 1 in vitro fertilization cycle in women using gonadotropin-releasing hormone antagonist protocol vs. progestin-primed ovarian stimulation: a propensity score-matched study.
Chen H; Teng XM; Sun ZL; Yao D; Wang Z; Chen ZQ
Fertil Steril; 2022 Oct; 118(4):701-712. PubMed ID: 35940929
[TBL] [Abstract][Full Text] [Related]
11. Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol.
Huang TC; Huang MZ; Seow KM; Yang IJ; Pan SP; Chen MJ; Hwang JL; Chen SU
Sci Rep; 2021 Nov; 11(1):22732. PubMed ID: 34815477
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis.
Du M; Zhang J; Li Z; Liu X; Li J; Liu W; Guan Y
Front Endocrinol (Lausanne); 2021; 12():705264. PubMed ID: 34589055
[TBL] [Abstract][Full Text] [Related]
13. Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First
Tu X; You B; Jing M; Lin C; Zhang R
Front Endocrinol (Lausanne); 2021; 12():801026. PubMed ID: 35140685
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the neonatal outcomes of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols: a propensity score-matched cohort study.
Du M; Zhang J; Ren B; Guan Y
Front Endocrinol (Lausanne); 2023; 14():1156620. PubMed ID: 37396165
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Cumulative Live Birth Rates Between Progestin and GnRH Analogues in Preimplantation Genetic Testing Cycles.
Zhou R; Dong M; Huang L; Wang S; Wang Z; Xu L; Zhang X; Liu F
J Clin Endocrinol Metab; 2023 Dec; 109(1):217-226. PubMed ID: 37450562
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study.
Zhang S; Yin Y; Li Q; Zhang C
Front Endocrinol (Lausanne); 2021; 12():644456. PubMed ID: 34234739
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the pregnancy outcomes of progestin-primed vs. antagonist ovarian stimulation in patients with poor ovarian response: a retrospective study.
Shi Z; Zhao W; Wu X; Bi X
Gynecol Endocrinol; 2024 May; 40(1):2352133. PubMed ID: 38749017
[TBL] [Abstract][Full Text] [Related]
18. Fertility outcomes in women after controlled ovarian stimulation with gonadotropin releasing hormone agonist long protocol: fresh versus frozen embryo transfer.
Ding X; Yang J; Li L; Yang N; Lan L; Huang G; Ye H
BMC Pregnancy Childbirth; 2021 Mar; 21(1):207. PubMed ID: 33711956
[TBL] [Abstract][Full Text] [Related]
19. Letrozole cotreatment progestin-primed ovarian stimulation in women undergoing controlled ovarian stimulation for in vitro fertilization.
Wang X; Zhang Y; Diao H; Jiang S; Zhang C
J Obstet Gynaecol Res; 2024 May; 50(5):890-898. PubMed ID: 38403851
[TBL] [Abstract][Full Text] [Related]
20. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
